Abstract
Background: High bleeding risk (HBR) is associated with an increased risk of both ischemic and bleeding events and is known to have a worse prognosis than non‐HBR in patients with acute myocardial infarction. However, data regarding the prognostic impact of complete revascularization (CR) in acute myocardial infarction and multivessel disease patients complicated by HBR remain limited. Methods: A total of 13 460 patients with acute myocardial infarction and multivessel disease who underwent successful percutaneous coronary intervention for infarct‐related artery were selected from the nationwide Korean registry from 2011 to 2020. Primary outcome was major adverse cardiac and cerebrovascular events during 3 years of follow‐up. Results: Of the 13 460 patients, 4401 (32.7%) were classified as the group with HBR according to modified Academic Research Consortium‐HBR criteria and 1577 patients (35.8%) underwent CR. Among the group without HBR, 3911 patients (43.2%) underwent CR for noninfarct‐related artery. The group with HBR had significantly higher risk of major adverse cardiac and cerebrovascular events (non‐HBR versus HBR; 16.4% versus 35.7%; adjusted hazard ratio [HR], 1.70 [95% CI, 1.56–1.85]; P P P P P =0.572) and without HBR (4.2% versus 5.0%, adjusted HR, 0.98 [95% CI, 0.78–1.23], P =0.867). Conclusions: In patients with acute myocardial infarction and multivessel disease, CR was associated with a lower risk of major adverse cardiac and cerebrovascular events compared with incomplete revascularization in both HBR and non‐HBR. Registration: KAMIR‐NIH; KCT‐0000863, KAMIR‐V; KCT‐0008355.

This publication has 31 references indexed in Scilit: